Despite the existing therapies, cancer patients still suffer from the ineffectiveness of these treatments, their toxicities, and the risk of relapse. Our proposed Stem Cell-Based iNKT Cell Therapy represents a novel therapy for cancer that can potentially help many cancer patients.

Project Objective

Pre-IND meeting

Major Proposed Activities

Conduction of Preclinical Studies

Development of a Clinical Trial Protocol

Preparation for and Conduction of a Pre-IND Meeting with the FDA

Statement of Benefit to California:

Cancer is a leading threat to public health in the United States and in the State of California. In 2015, it is estimated that over 160,000 Californians can be diagnosed with cancer. Cancer is the second leading cause of death in California, and also brings devastating economic impacts to the State. Our proposed Stem Cell-Based iNKT Cell Therapy, if successful, has the potential to save the lives of Californians and reduce the economic burden for cancer treatment.